OTHER · Unmapped registry intervention
Biological samples
Find medicine records ·
Find other trials using this name
Clinical trial
Study of Anti-telomerase T CD4 Immunity in Metastatic Lung Cancer
NCT02846103
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedStudy of Anti-telomerase T CD4 Immunity in Metastatic Lung Cancer
Design: INTERVENTIONAL · Status: COMPLETED · Phase: NA
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Lung Cancerverified · MONDO: lung cancer
Interventions
Biological samplesOTHER
Sponsors & collaborators
Centre Hospitalier Universitaire de Besanconlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02846103 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.